BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35028410)

  • 1. Influence of severe anemia on procedural safety and one-year outcome after left atrial appendage closure: Insights from a very high-risk cohort.
    Kany S; Brachmann J; Lewalter T; Akin I; Sievert H; Zeymer U; Hochadel M; Senges J; Kirchhof P; Lubos E
    Int J Cardiol Heart Vasc; 2022 Feb; 38():100946. PubMed ID: 35028410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
    Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
    J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of atrial fibrillation pattern on outcomes after left atrial appendage closure: lessons from the prospective LAARGE registry.
    Kany S; Brachmann J; Lewalter T; Akin I; Sievert H; Zeymer U; Ledwoch J; Ince H; Thomas D; Hochadel M; Senges J; Kirchhof P; Rillig A
    Clin Res Cardiol; 2022 May; 111(5):511-521. PubMed ID: 34043052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison in Patients < 75 Years of Age - Versus - Those > 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the Prospective Multicenter German LAARGE Registry).
    Nasasra AE; Brachmann J; Lewalter T; Akin I; Sievert H; Nienaber CA; Weiß C; Pleger ST; Ince H; Maier J; Achenbach S; Sigusch HH; Hochadel M; Schneider S; Senges J; Zeymer U
    Am J Cardiol; 2020 Dec; 136():81-86. PubMed ID: 32946860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure for prevention of death, stroke, and bleeding in patients with nonvalvular atrial fibrillation.
    Gloekler S; Saw J; Koskinas KC; Kleinecke C; Jung W; Nietlispach F; Meier B
    Int J Cardiol; 2017 Dec; 249():234-246. PubMed ID: 28882323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility and safety of "one-stop" left atrial appendage closure and percutaneous coronary intervention in atrial fibrillation patients with significant coronary artery disease (PCI-LAAC study).
    Wang Y; Wu D; Ma J; Liu X; Zhang H; So CY; Lam YY; Wang B; Wang J; Zhang H; Wang M; Song G; Wu Y
    Am J Cardiovasc Dis; 2021; 11(5):679-687. PubMed ID: 34849300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
    Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
    Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.
    Fastner C; Brachmann J; Lewalter T; Zeymer U; Sievert H; Borggrefe M; Nienaber CA; Weiß C; Pleger ST; Ince H; Maier J; Achenbach S; Sigusch HH; Hochadel M; Schneider S; Senges J; Akin I
    Clin Res Cardiol; 2021 Jan; 110(1):12-20. PubMed ID: 32296971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage closure in patients with a reduced left ventricular ejection fraction: results from the multicenter German LAARGE registry.
    Fastner C; Brachmann J; Lewalter T; Zeymer U; Sievert H; Borggrefe M; Weiß C; Geist V; Krapivsky A; Käunicke M; Mudra H; Hochadel M; Schneider S; Senges J; Akin I
    Clin Res Cardiol; 2020 Nov; 109(11):1333-1341. PubMed ID: 32236717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
    Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
    J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease.
    Lind A; Azizy O; Lortz J; Janosi A; Rassaf T; Rammos C
    Arch Med Sci; 2023; 19(2):331-336. PubMed ID: 37034526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke.
    Masjuan J; Salido L; DeFelipe A; Hernández-Antolín R; Fernández-Golfín C; Cruz-Culebras A; Matute C; Vera R; Pérez-Torre P; Zamorano JL
    Eur J Neurol; 2019 May; 26(5):816-820. PubMed ID: 30586229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry.
    Boersma LV; Schmidt B; Betts TR; Sievert H; Tamburino C; Teiger E; Pokushalov E; Kische S; Schmitz T; Stein KM; Bergmann MW;
    Eur Heart J; 2016 Aug; 37(31):2465-74. PubMed ID: 26822918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation Patients With Contraindications to Anticoagulation.
    Saw J; Bennell MC; Singh SM; Wijeysundera HC
    Can J Cardiol; 2016 Nov; 32(11):1355.e9-1355.e14. PubMed ID: 27432692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of Left Atrial Appendage Closure with the Amplatzer Cardiac Plug in Very High Stroke and Bleeding Risk Patients with Non-Valvular Atrial Fibrillation.
    Kebernik J; Jose J; Abdel-Wahab M; Stöcker B; Geist V; Richardt G
    Cardiol Ther; 2015 Dec; 4(2):167-77. PubMed ID: 26563411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage closure with WATCHMAN in Asian patients: 2 year outcomes from the WASP registry.
    Phillips KP; Santoso T; Sanders P; Alison J; Chan JLK; Pak HN; Chandavimol M; Stein KM; Gordon N; Razali OB
    Int J Cardiol Heart Vasc; 2019 Jun; 23():100358. PubMed ID: 31008181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared With Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation.
    Reddy VY; Akehurst RL; Amorosi SL; Gavaghan MB; Hertz DS; Holmes DR
    Stroke; 2018 Jun; 49(6):1464-1470. PubMed ID: 29739915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.